Rocket Doctor Adds 2.4M NY Members, Targeting Underserved Populations
- 2.4 million: New York residents added to Rocket Doctor's telehealth network
- 15 million: Total covered lives across Rocket Doctor's key U.S. markets
- 56%: Medicare Advantage enrollment rate among New York's Medicare beneficiaries
Experts would likely conclude that Rocket Doctor's expansion significantly enhances telehealth access for underserved populations in New York, particularly through its integration with government-sponsored health plans, addressing critical healthcare disparities.
Rocket Doctor Deal Expands Telehealth Access to 2.4 Million Vulnerable New Yorkers
NEW YORK, NY – March 03, 2026 – Digital health firm Rocket Doctor AI Inc. has secured a major new contract with an unnamed New York insurer, a move that extends in-network telehealth services to an additional 2.4 million state residents. The agreement significantly deepens the company's footprint in one of the nation's largest healthcare markets and underscores a strategic focus on integrating virtual care into government-sponsored health plans.
This latest partnership brings Rocket Doctor’s total reach to over 15 million covered lives across its key U.S. markets, primarily New York and California. The deal marks a significant step in the company's aggressive expansion, validating its model of embedding its AI-powered platform within established payer networks to reach patients who have historically faced barriers to care.
Under the terms of the agreement, eligible members across a wide spectrum of plans—including Medicaid Managed Care, Health and Recovery Plans (HARP), Medicare Advantage, Dual-Eligible Special Needs Plans (D-SNP), and Managed Long-Term Care—will gain in-network access to Rocket Doctor's network of board-certified physicians for medical, behavioral health, and ancillary services.
Bridging New York's Healthcare Divide
The contract's true significance lies in its target demographic. By focusing on Medicaid, Medicare Advantage, and specialized plans like HARP for individuals with serious mental illness, Rocket Doctor is positioning itself as a key player in addressing New York's healthcare disparities. New York's Medicaid program serves approximately 1.3 million residents, while 56% of the state's 2.59 million Medicare beneficiaries are enrolled in Medicare Advantage plans. These populations often face significant hurdles, including provider shortages in rural areas, long wait times for specialists, and difficulties accessing integrated behavioral healthcare.
Telehealth platforms like Rocket Doctor aim to directly mitigate these issues. By removing geographical barriers, the service allows a patient in a remote upstate community to consult with a specialist who might otherwise be inaccessible. This improves the timeliness of care, potentially preventing minor issues from escalating into costly emergency room visits. The explicit inclusion of behavioral health services is particularly critical for HARP members, who require coordinated care that the traditional system often struggles to provide.
“This agreement significantly expands Rocket Doctor’s ability to reach patients across New York, particularly in high-need and government-sponsored programs,” said Dr. William Cherniak, Co-Founder and CEO of Rocket Doctor Inc., in a statement. “This insurer’s scale and strong presence in Medicaid, Medicare Advantage, and individual plans make this partnership a meaningful step forward in our mission to improve access to timely, high-quality care for underserved and mainstream populations alike.”
This expansion builds on a previous announcement from October 2025, when Rocket Doctor added 3.8 million members in New York through contracts with two other major insurers, signaling a sustained and successful push into the state's complex payer landscape.
A Differentiating Strategy in a Crowded Market
The U.S. telehealth market is fiercely competitive, dominated by national giants like Teladoc Health and Amwell. However, Rocket Doctor is carving out a niche with a dual-pronged strategy: securing large-scale government payer contracts and leveraging a physician-centric, AI-powered platform.
While many competitors focus on employer-sponsored or direct-to-consumer models, Rocket Doctor's deep integration with Medicaid and Medicare plans sets it apart. This approach not only provides access to a massive and often overlooked patient base but also aligns with state and federal goals of improving health equity and reducing costs.
Technologically, the company emphasizes its physician-built roots. Its platform, which has already empowered over 300 physicians across more than 700,000 patient visits, is designed to restore physician autonomy and reduce administrative burnout. A key component is the Global Library of Medicine (GLM), a clinically validated AI decision support system. Unlike basic administrative AI, the GLM is intended to assist physicians in the diagnostic process, ensuring consistency and quality of care. This focus on empowering providers is a crucial element in attracting the clinical talent needed to serve its rapidly growing network.
The Business Behind the Mission
For the publicly traded parent company, Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF), these large-scale contracts are critical for demonstrating market validation and charting a path to profitability. The company, which was acquired by Treatment.com AI Inc. in early 2025, has faced analyst concerns regarding cash burn and operating losses despite its rapid growth in network access. The successful conversion of its 15 million covered lives into active, revenue-generating patient visits will be the ultimate test of its business model.
Operationally, the expansion presents a significant challenge. Scaling to effectively serve millions of new members requires a robust and rapid expansion of its physician network, including the time-consuming process of credentialing doctors with the new insurance partner. Furthermore, the company's technology infrastructure must prove resilient and capable of handling a substantial increase in patient volume without compromising the quality of the user experience for either patients or providers.
The integration of its platform with the broader Treatment.com AI ecosystem, including a planned AI Nurse for patient triage, is expected to create synergies and drive efficiency. By automating tasks like patient history collection and medical note-taking, the company hopes its AI can allow physicians to focus more on direct patient interaction, enhancing the quality of care even at scale. This contract represents a pivotal moment, testing whether Rocket Doctor's blend of strategic payer partnerships and advanced technology can successfully transform healthcare access for millions.
